Form 4: Recursion Pharmaceuticals Director Acquires Shares Under Compensation Policy

Director Zavain Dar acquired 1,843 shares of Recursion Pharmaceuticals' Class A Common Stock on July 1, 2024, under the company's Outside Director Compensation Policy.

Summary

• On July 1, 2024, Zavain Dar, a director of Recursion Pharmaceuticals, acquired 1,843 shares of Class A Common Stock.
• The acquisition was made under the Issuer's Outside Director Compensation Policy.
• Following the transaction, Dar directly owns 103,996 shares of Recursion Pharmaceuticals.
• The transaction was reported on July 3, 2024.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares under a compensation plan is generally a good sign, indicating confidence in the company's prospects, but it's also a routine transaction.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.

Industry Context

Director share acquisitions are common and can be seen as a positive signal, indicating confidence in the company's future performance.

Stakeholder Impact

• The acquisition of shares by a director may have a slightly positive impact on shareholder confidence.

Key Dates